![](/img/cover-not-exists.png)
A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy
Twardowski, Przemyslaw W., Beumer, Jan H., Chen, C.S., Kraft, Andrew S., Chatta, Gurkamal S., Mitsuhashi, Masato, Ye, Wei, Christner, Susan M., Lilly, Michael B.Volume:
24
Language:
english
Journal:
Anti-Cancer Drugs
DOI:
10.1097/CAD.0b013e328361feb0
Date:
August, 2013
File:
PDF, 780 KB
english, 2013